Mojca Frank-Bertoncelj
Overview
Explore the profile of Mojca Frank-Bertoncelj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
526
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burja B, Paul D, Tastanova A, Edalat S, Gerber R, Houtman M, et al.
Front Cell Dev Biol
. 2022 May;
10:872688.
PMID: 35573685
We present an optimized dissociation protocol for preparing high-quality skin cell suspensions for in-depth single-cell RNA-sequencing (scRNA-seq) analysis of fresh and cultured human skin. Our protocol enabled the isolation of...
2.
Kuret T, Frank-Bertoncelj M, Lakota K, Zigon P, Thallinger G, Kopitar A, et al.
Front Med (Lausanne)
. 2022 Feb;
8:827095.
PMID: 35127774
In the present study, we longitudinally monitored leukocyte subsets, expression of neutrophil surface adhesion molecules (CD62L and CD11b) and serum analytes in therapy-naïve patients with active giant cell arteritis (GCA)....
3.
Micheroli R, Elhai M, Edalat S, Frank-Bertoncelj M, Burki K, Ciurea A, et al.
RMD Open
. 2022 Jan;
8(1).
PMID: 34987094
Objectives: To integrate published single-cell RNA sequencing (scRNA-seq) data and assess the contribution of synovial fibroblast (SF) subsets to synovial pathotypes and respective clinical characteristics in treatment-naïve early arthritis. Methods:...
4.
Morante-Palacios O, Ciudad L, Micheroli R, de la Calle-Fabregat C, Li T, Barbisan G, et al.
Nucleic Acids Res
. 2021 Dec;
50(1):108-126.
PMID: 34893889
Glucocorticoids (GCs) exert potent anti-inflammatory effects in immune cells through the glucocorticoid receptor (GR). Dendritic cells (DCs), central actors for coordinating immune responses, acquire tolerogenic properties in response to GCs....
5.
Ge X, Frank-Bertoncelj M, Klein K, McGovern A, Kuret T, Houtman M, et al.
Genome Biol
. 2021 Aug;
22(1):247.
PMID: 34433485
Background: Genome-wide association studies have reported more than 100 risk loci for rheumatoid arthritis (RA). These loci are shown to be enriched in immune cell-specific enhancers, but the analysis so...
6.
Kuret T, Lakota K, cucnik S, Jurcic V, Distler O, Rotar Z, et al.
Int J Mol Sci
. 2021 Jul;
22(12).
PMID: 34204585
In this study, we explored expression of microRNA (miR), miR-target genes and matrix remodelling molecules in temporal artery biopsies (TABs) from treatment-naïve patients with giant cell arteritis (GCA, = 41)...
7.
Pachera E, Assassi S, Salazar G, Stellato M, Renoux F, Wunderlin A, et al.
J Clin Invest
. 2020 Jul;
130(9):4888-4905.
PMID: 32603313
TGF-β is a master regulator of fibrosis, driving the differentiation of fibroblasts into apoptosis-resistant myofibroblasts and sustaining the production of extracellular matrix (ECM) components. Here, we identified the nuclear long...
8.
Bolha L, Pizem J, Frank-Bertoncelj M, Hocevar A, Tomsic M, Jurcic V
Rheumatology (Oxford)
. 2020 Jun;
59(11):3540-3552.
PMID: 32594153
Objectives: To identify dysregulated microRNAs (miRNAs) and their gene targets in temporal arteries from GCA patients, and determine their association with GCA pathogenesis and related arterial wall remodelling. Methods: We...
9.
Burja B, Mertelj T, Frank-Bertoncelj M
Front Med (Lausanne)
. 2020 May;
7:124.
PMID: 32432116
The Janus kinase (JAK)-Signal transducer and activator of transcription (STAT) pathway is one of the central signaling hubs in inflammatory, immune and cancer cells. Inhibiting the JAK-STAT pathway with JAK...
10.
Stok U, Blokar E, Lenassi M, Holcar M, Frank-Bertoncelj M, Erman A, et al.
Cells
. 2020 May;
9(5).
PMID: 32414170
Antiphospholipid syndrome (APS) is a systemic autoimmune disease, characterized by thrombosis, obstetric complications and the presence of antiphospholipid antibodies (aPL), which drive endothelial injury and thrombophilia. Extracellular vesicles (EVs) have...